Literature DB >> 23652846

Acute myocardial infarction: early CT aspects of myocardial microcirculation obstruction after percutaneous coronary intervention.

Charles Amanieu1, Ingrid Sanchez, Simona Arion, Eric Bonnefoy, Didier Revel, Philippe Douek, Loic Boussel.   

Abstract

OBJECTIVE: To evaluate the capabilities of delayed enhanced multidetector CT (DE-MDCT), performed immediately after percutaneous coronary intervention (PCI), in predicting myocardial microvascular obstruction (MVO) formation assessed by delayed enhanced MRI (DE-MRI).
METHODS: Thirty-two patients presenting with a primary acute myocardial infarction, successfully recanalised by PCI, underwent a DE-MDCT immediately after PCI and a DE-MRI within 1 week. The left ventricle was split into 64 subsegments, rated as "healthy", "infarcted" or "MVO" on DE-MRI. Their mean density was measured on DE-MDCT and calculated relative to the patient's mean healthy myocardium density. Hypoenhanced DE-MDCT subsegments, termed "CT early MVO", were also recorded. Sensitivity and specificity of DE-MDCT for MRI-assessed "MVO" subsegments detection was calculated for mean CT relative density (threshold determined from a ROC analysis), "CT early MVO" and both.
RESULTS: Mean CT relative density was higher in MRI-assessed "MVO" than in "infarcted" and "healthy" subsegments (1.82 ± 0.46, 1.43 ± 0.36 and 1.0 ± 0.13 respectively; P < 0.001) leading to a sensitivity and specificity of 94.3 % and 89.2 % for a cutoff of 1.36. Sensitivity and specificity were respectively 16.9 % and 99.8 % for "CT early MVO" and 95.3 % and 89.3 % when considering the two patterns.
CONCLUSION: DE-MDCT, performed immediately after PCI, allows for an accurate prediction of MVO formation. KEY POINTS: • Myocardial microvascular obstruction (MVO) is an important prognostic sequel following myocardial infarction. • MVO can be accurately predicted by multidector CT (MDCT). • Both hypo- and hyperenhanced myocardial areas can be analysed by MDCT. • MDCT may become a useful prognostic tool for acute MI outcome.

Entities:  

Mesh:

Year:  2013        PMID: 23652846     DOI: 10.1007/s00330-013-2853-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.

Authors:  Albert C Lardo; Marco A S Cordeiro; Caterina Silva; Luciano C Amado; Richard T George; Anastasios P Saliaris; Karl H Schuleri; Veronica R Fernandes; Menekhem Zviman; Saman Nazarian; Henry R Halperin; Katherine C Wu; Joshua M Hare; Joao A C Lima
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

3.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients.

Authors:  T Killip; J T Kimball
Journal:  Am J Cardiol       Date:  1967-10       Impact factor: 2.778

4.  Local effects of acute cellular injury on regional myocardial blood flow.

Authors:  F R Cobb; R J Bache; F Rivas; J C Greenfield
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

5.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

6.  Multidetector computed tomography in reperfused acute myocardial infarction. Assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging.

Authors:  Alexis Jacquier; Loïc Boussel; Nicolas Amabile; Jean Michel Bartoli; Philipe Douek; Guy Moulin; Franck Paganelli; Maythem Saeed; Didier Revel; Pierre Croisille
Journal:  Invest Radiol       Date:  2008-11       Impact factor: 6.016

7.  Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance.

Authors:  Cristina Basso; Francesco Corbetti; Caterina Silva; Aierken Abudureheman; Carmelo Lacognata; Luisa Cacciavillani; Giuseppe Tarantini; Martina Perazzolo Marra; Angelo Ramondo; Gaetano Thiene; Sabino Iliceto
Journal:  Am J Cardiol       Date:  2007-08-15       Impact factor: 2.778

8.  Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction.

Authors:  Leonardo Bolognese; Nazario Carrabba; Guido Parodi; Giovanni M Santoro; Piergiovanni Buonamici; Giampaolo Cerisano; David Antoniucci
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

9.  Identification of residual ischemia, infarction, and microvascular impairment in revascularized myocardial infarction using 64-slice MDCT.

Authors:  Andre D Furtado; Marcus Carlsson; Max Wintermark; Karen Ordovas; Maythem Saeed
Journal:  Contrast Media Mol Imaging       Date:  2008 Sep-Oct       Impact factor: 3.161

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  1 in total

Review 1.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.